Condition
Neurological Abnormality
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07182474Recruiting
Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE)
NCT05971329Not ApplicableRecruiting
Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
NCT04643548Unknown
WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients
Showing all 3 trials